Axsome Therapeutics Stock Forecast NASDAQ:AXSM
Price Target and Analyst Ratings
Historical Ratings
Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
2022-05-03 | 58.99% | Mizuho | $51.00 $49.00 | Maintains | Buy |
2022-04-27 | -12.39% | Morgan Stanley | $34.00 $27.00 | Maintains | Equal-Weight |
2022-03-29 | 149.84% | Jefferies | $71.00 $77.00 | Maintains | Buy |
2022-03-02 | 62.23% | SVB Leerink | $65.00 $50.00 | Maintains | Outperform |
2021-11-09 | 110.9% | SVB Leerink | $75.00 $65.00 | Maintains | Outperform |
2021-08-30 | 484.04% | HC Wainwright & Co. | $225.00 $180.00 | Maintains | Buy |
2021-08-10 | 419.14% | Truist Securities | $200.00 $160.00 | Maintains | Buy |
2021-08-10 | 10.32% | Morgan Stanley | $105.00 $34.00 | Downgrades | Overweight Equal-Weight |
2021-08-10 | 143.35% | SVB Leerink | $115.00 $75.00 | Maintains | Outperform |
2021-08-10 | 78.46% | Mizuho | $118.00 $55.00 | Maintains | Buy |
2021-06-10 | 263.4% | Berenberg | $112.00 | Initiates Coverage On | Buy |
2021-05-26 | 240.69% | Morgan Stanley | $104.00 $105.00 | Maintains | Overweight |
2021-04-27 | 630.05% | HC Wainwright & Co. | $210.00 $225.00 | Maintains | Buy |
2021-03-02 | 237.44% | Morgan Stanley | $101.00 $104.00 | Maintains | Overweight |
2021-01-08 | 318.56% | Jefferies | $129.00 | Initiates Coverage On | Buy |
2020-12-16 | 289.36% | Mizuho | $120.00 | Initiates Coverage On | Buy |
2020-11-09 | 227.71% | Morgan Stanley | $102.00 $101.00 | Maintains | Overweight |
2020-09-29 | 114.15% | B of A Securities | $66.00 | Initiates Coverage On | Underperform |
2020-09-10 | 230.95% | Morgan Stanley | $102.00 | Initiates Coverage On | Overweight |
2020-04-28 | 581.38% | HC Wainwright & Co. | $200.00 $210.00 | Maintains | Buy |
2020-04-28 | 325.05% | Cantor Fitzgerald | $125.00 $131.00 | Maintains | Overweight |
2020-04-14 | 208.24% | Cowen & Co. | $95.00 | Initiates Coverage On | Outperform |
2019-12-30 | 305.58% | Cantor Fitzgerald | $104.00 $125.00 | Reiterates | Overweight |
2019-12-30 | 548.93% | HC Wainwright & Co. | $170.00 $200.00 | Maintains | Buy |
2019-12-16 | 412.65% | Guggenheim | $65.00 $158.00 | Maintains | Buy |
2019-12-16 | 237.44% | Cantor Fitzgerald | $55.00 $104.00 | Maintains | Overweight |
2019-10-16 | 55.74% | Guggenheim | $48.00 | Initiates Coverage On | Buy |
2019-09-18 | - | William Blair | - | Initiates Coverage On | Outperform |
AXSM Stock Trend
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 7.81% during the next 3 months and, with a 90% probability hold a price between $27.44 and $52.16 at the end of this 3-month period.
Data
Date | Bottom | Mid | Top |
---|---|---|---|
2022-05-18 | $25.52 | $36.98 | $48.44 |
2022-05-19 | $25.57 | $37.04 | $48.50 |
2022-05-20 | $25.63 | $37.10 | $48.56 |
2022-05-23 | $25.69 | $37.15 | $48.62 |
2022-05-24 | $25.75 | $37.21 | $48.68 |
2022-05-25 | $25.81 | $37.27 | $48.74 |
2022-05-26 | $25.87 | $37.33 | $48.79 |
2022-05-27 | $25.92 | $37.39 | $48.85 |
2022-05-31 | $25.98 | $37.45 | $48.91 |
2022-06-01 | $26.04 | $37.50 | $48.97 |
2022-06-02 | $26.10 | $37.56 | $49.03 |
2022-06-03 | $26.16 | $37.62 | $49.09 |
2022-06-06 | $26.22 | $37.68 | $49.14 |
2022-06-07 | $26.27 | $37.74 | $49.20 |
2022-06-08 | $26.33 | $37.80 | $49.26 |
2022-06-09 | $26.39 | $37.86 | $49.32 |
2022-06-10 | $26.45 | $37.91 | $49.38 |
2022-06-13 | $26.51 | $37.97 | $49.44 |
2022-06-14 | $26.57 | $38.03 | $49.49 |
2022-06-15 | $26.62 | $38.09 | $49.55 |
2022-06-16 | $26.68 | $38.15 | $49.61 |
2022-06-17 | $26.74 | $38.21 | $49.67 |
2022-06-21 | $26.80 | $38.26 | $49.73 |
2022-06-22 | $26.86 | $38.32 | $49.79 |
2022-06-23 | $26.92 | $38.38 | $49.84 |
2022-06-24 | $26.97 | $38.44 | $49.90 |
2022-06-27 | $27.03 | $38.50 | $49.96 |
2022-06-28 | $27.09 | $38.56 | $50.02 |
2022-06-29 | $27.15 | $38.61 | $50.08 |
2022-06-30 | $27.21 | $38.67 | $50.14 |
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.